Home
About
FAQ
History (35)
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
Nitric oxide scavenging by red cell microparticles.
Re: Antagonists of Growth Hormone-Releasing Hormone Inhibit Proliferation Induced by Inflammation in Prostatic Epithelial Cells.
Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system.
Re: Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Re: Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.
Atala A. Re: Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. J Urol. 2017 03; 197(3 Pt 1):701-702.
View in:
PubMed
subject areas
Humans
Male
Prostatic Neoplasms
Receptor, erbB-2
authors with profiles
Anthony Atala MD